BioCentury | Jul 28, 2008
Company News

Velcura board of directors update

Velcura Therapeutics Inc. , Ann Arbor, Mich. Business: Musculoskeletal, Cancer Appointed: William Brinkerhoff, COO of Cerenis Therapeutics S.A. WIR Staff cancer Musculoskeletal...
BioCentury | May 19, 2008
Clinical News

VEL-0230: Preliminary Phase I data

...reduced CTx levels by 80% within 15 minutes. CTx is a biomarker of bone resorption. Velcura Therapeutics Inc....
BioCentury | Oct 22, 2007
Company News

Velcura management update

Velcura Therapeutics Inc. , Ann Arbor, Mich. Business: Musculoskeletal, Cancer Hired: Jeffrey Fellows as VP of regulatory affairs, formerly VP of regulatory affairs at Cell Therapeutics Inc. WIR Staff...
BioCentury | Oct 8, 2007
Company News

Velcura management update

Velcura Therapeutics Inc. , Ann Arbor, Mich. Business: Musculoskeletal Hired: Richard Dyer as EVP of product development; formerly VP of scientific affairs and development at TCH Pharmaceuticals Inc. WIR Staff Musculoskeletal...
BioCentury | Oct 1, 2007
Clinical News

VEL-0230: Phase Ia start

...In 1Q08, Velcura plans to begin an open-label, dose-escalation Phase Ia trial of oral VEL-0230. Velcura Therapeutics Inc....
BioCentury | Oct 1, 2007
Clinical News

VEL-0230: Phase Ib start

...In 2H08, Velcura plans to begin a dose-escalation Phase Ib trial. Velcura Therapeutics Inc. , Ann Arbor, Mich...
BioCentury | May 14, 2007
Company News

Velcura management update

Velcura Therapeutics Inc. , Ann Arbor, Mich. Business: Musculoskeletal Hired: Bill Cadwallader as EVP of corporate development, formerly VP of strategic planning and marketing at Cell Therapeutics Inc. WIR Staff Musculoskeletal...
BioCentury | Nov 14, 2005
Company News

GeneGo Inc., Velcura deal

...for target identification and validation, and for biomarker identification. GeneGo Inc. , St. Joseph, Mich. Velcura Therapeutics Inc....
BioCentury | Aug 15, 2005
Company News

Velcura, Chemiphar deal

...deal is expected to begin clinical trials to treat osteoporosis in 2006. Also, Nippon granted Velcura...
...Asia, and Velcura will have rights in the U.S., Europe and other markets outside Asia. Velcura Therapeutics Inc....
BioCentury | Jan 10, 2005
Company News

Velcura board of directors update

Velcura Therapeutics Inc. , Ann Arbor, Mich. Business: Musculoskeletal Appointed: Fred Beyerlein, president and CEO of Rubicon Genomics Inc. WIR Staff...
Items per page:
1 - 10 of 12
BioCentury | Jul 28, 2008
Company News

Velcura board of directors update

Velcura Therapeutics Inc. , Ann Arbor, Mich. Business: Musculoskeletal, Cancer Appointed: William Brinkerhoff, COO of Cerenis Therapeutics S.A. WIR Staff cancer Musculoskeletal...
BioCentury | May 19, 2008
Clinical News

VEL-0230: Preliminary Phase I data

...reduced CTx levels by 80% within 15 minutes. CTx is a biomarker of bone resorption. Velcura Therapeutics Inc....
BioCentury | Oct 22, 2007
Company News

Velcura management update

Velcura Therapeutics Inc. , Ann Arbor, Mich. Business: Musculoskeletal, Cancer Hired: Jeffrey Fellows as VP of regulatory affairs, formerly VP of regulatory affairs at Cell Therapeutics Inc. WIR Staff...
BioCentury | Oct 8, 2007
Company News

Velcura management update

Velcura Therapeutics Inc. , Ann Arbor, Mich. Business: Musculoskeletal Hired: Richard Dyer as EVP of product development; formerly VP of scientific affairs and development at TCH Pharmaceuticals Inc. WIR Staff Musculoskeletal...
BioCentury | Oct 1, 2007
Clinical News

VEL-0230: Phase Ia start

...In 1Q08, Velcura plans to begin an open-label, dose-escalation Phase Ia trial of oral VEL-0230. Velcura Therapeutics Inc....
BioCentury | Oct 1, 2007
Clinical News

VEL-0230: Phase Ib start

...In 2H08, Velcura plans to begin a dose-escalation Phase Ib trial. Velcura Therapeutics Inc. , Ann Arbor, Mich...
BioCentury | May 14, 2007
Company News

Velcura management update

Velcura Therapeutics Inc. , Ann Arbor, Mich. Business: Musculoskeletal Hired: Bill Cadwallader as EVP of corporate development, formerly VP of strategic planning and marketing at Cell Therapeutics Inc. WIR Staff Musculoskeletal...
BioCentury | Nov 14, 2005
Company News

GeneGo Inc., Velcura deal

...for target identification and validation, and for biomarker identification. GeneGo Inc. , St. Joseph, Mich. Velcura Therapeutics Inc....
BioCentury | Aug 15, 2005
Company News

Velcura, Chemiphar deal

...deal is expected to begin clinical trials to treat osteoporosis in 2006. Also, Nippon granted Velcura...
...Asia, and Velcura will have rights in the U.S., Europe and other markets outside Asia. Velcura Therapeutics Inc....
BioCentury | Jan 10, 2005
Company News

Velcura board of directors update

Velcura Therapeutics Inc. , Ann Arbor, Mich. Business: Musculoskeletal Appointed: Fred Beyerlein, president and CEO of Rubicon Genomics Inc. WIR Staff...
Items per page:
1 - 10 of 12